SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Fundrise Growth Tech Fund LLC operates as a non-diversified, closed-end management investment company. It invests in growing tech companies to help them expand and generate profits. The company was founded on June 7, 2021 and is headquartered in Washington, DC.

Fundrise Innovation Fund LLC. - Common Shares of Limited Liability Company Interests

Fundrise Innovation Fund 

The Fundrise Innovation Fund ($VCX) is seeing intense retail frenzy and extreme volatility, driven by investor scramble for exposure to private AI and space unicorns like Anthropic, OpenAI, and SpaceX. While some traders are riding the momentum and betting on further gains, community sentiment is heavily polarized due to concerns over its massive premium to net asset value, a restricted share lockup preventing easy selling, and comparisons to other vehicles like $ORBS or $DXYZ.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is trending as investors debate the impact of a bipartisan Senate bill aimed at restricting sports betting contracts on prediction market platforms. While some community members view the legislation as a competitive win that reinforces the company's regulatory moat, others remain skeptical, citing continued insider selling and broader sector volatility.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is experiencing positive market sentiment driven by the announced departure of a key FDA official, which investors perceive as a catalyst for a more favorable regulatory environment for its gene therapy pipeline. Community members are actively discussing the stock's significant short interest and the anticipation of upcoming clinical data readouts, fueling speculation about potential institutional accumulation and short-term volatility.

FuboTV, Inc. is a consumer-first live TV streaming company with the mission of delivering premium sports, news and entertainment programming that offers greater choice, flexibility and value. The company was founded by David Gandler, Alberto Horihuela Suarez, and Sung Ho Choi on February 20, 2009 and is headquartered in New York, NY.

fuboTV Inc - Ordinary Shares - Class A

fuboTV Inc

FuboTV is facing intense backlash and downward pressure following the confirmation of a 1-for-12 reverse stock split, with retail investors expressing deep frustration over management's lack of communication and strategic direction. The community is heavily debating the company's long-term viability, with many investors calling for accountability while others attempt to analyze the impact of the reduced share float on potential institutional interest and short-squeeze opportunities.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is seeing significant market activity as investors weigh the potential catalyst of a SpaceX IPO against the companys own upcoming BlueBird 7 launch. The community remains heavily divided between long-term holders betting on institutional partnerships and the broader space sector growth, and skeptical traders voicing frustration over launch delays and insider activity.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is facing significant downward pressure following its fiscal Q2 2026 earnings, as investors react to a large debt repurchase tender offer and increased capital expenditure guidance despite strong underlying demand. The community is actively debating whether this pullback represents a classic cyclical correction, an overreaction to external geopolitical tensions and peer valuation assessments, or a deliberate market manipulation, with many investors split between loading up on what they view as a deeply undervalued stock and fearing further technical breakdowns.

Destiny Tech100, Inc. operates as a non-diversified, closed-end management investment company. The company was founded on November 18, 2020 and is headquartered in Austin, TX.

Destiny Tech100 Inc

DESTINY TECH 100 INC

Destiny Tech 100 is seeing significant retail interest fueled by speculation around an upcoming SpaceX IPO and the fund's heavy exposure to major private tech companies like Anthropic and OpenAI. While the community is actively debating the fund's massive premium over its net asset value, many traders are treating it as a high-volatility proxy play, with bulls looking for a short squeeze while others caution against the fund's structure.

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing and Plasma Collection Center. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Adma Biologics Inc

ADMA Biologics is experiencing extreme volatility and intense community debate following a provocative short report from Culper Research that alleges aggressive channel stuffing practices. While management has issued a rebuttal calling the assertions misleading and false, investors remain deeply divided, with many aggressively adding to their positions in anticipation of a rebound while others express frustration over the perceived weakness of the response and the resulting share price pressure.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines is experiencing significant momentum and heavy trading volume as investors react to the company's expanding role in NASA's updated Artemis lunar base infrastructure plans and anticipation of upcoming contract awards. The community is actively debating the stock's volatility and growth prospects, with many bulls focusing on the company's long-term potential as a key service provider for sustained lunar operations.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

Alphabet is seeing heightened market attention as the company navigates strategic AI infrastructure expansions and partnerships, including recent efforts to deploy Gemini AI agents within the Pentagon's workforce. While investors remain focused on the company's long-term growth potential and data center investments, market sentiment is currently being pressured by broader geopolitical uncertainty and volatility affecting the tech sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

GRAL DROPS ~50% -- REPORTED NUMBERS VS. ACTUAL RESULTS; LEVI & KORSINSKY, LLP INVESTIGATES

GRAL DROPS ~50% -- REPORTED NUMBERS VS. ACTUAL RESULTS; LEVI & KORSINSKY, LLP INVESTIGATES GRAL DROPS ~50% -- REPORTED NUMBERS VS. ACTUAL RESULTS; LEVI & KORSINSKY, LLP INVESTIGATES PR Newswire NEW...

GRAIL (NASDAQ:GRAL) Trading Up 6.9% Following Analyst Upgrade

GRAIL (NASDAQ:GRAL) Trading Up 6.9% After Analyst Upgrade...

LEVI & KORSINSKY, LLP: GRAIL (GRAL) GUIDED TO 2030 CASH RUNWAY WHILE KEY TRIAL RISK WENT UNADDRESSED

LEVI & KORSINSKY, LLP: GRAIL (GRAL) GUIDED TO 2030 CASH RUNWAY WHILE KEY TRIAL RISK WENT UNADDRESSED LEVI & KORSINSKY, LLP: GRAIL (GRAL) GUIDED TO 2030 CASH RUNWAY WHILE KEY TRIAL RISK WENT...

GRAIL (NASDAQ:GRAL) Raised to Buy at TD Cowen

TD Cowen raised shares of GRAIL from a "hold" rating to a "buy" rating and set a $65.00 target price for the company in a research note on Wednesday...

Futures Slump, Erasing Overnight Gains After Iran's Giant Pars Field Attacked; FOMC Looms

Futures Slump, Erasing Overnight Gains After Iran's Giant Pars Field Attacked; FOMC Looms Stocks were set to extend gains into a third day as Iraq's deal to reroute crude via Turkey, bypassing the...

GRAIL, Inc. (NASDAQ:GRAL) Sees Significant Increase in Short Interest

GRAIL, Inc. (NASDAQ:GRAL - Get Free Report) was the recipient of a significant increase in short interest in the month of February. As of February 27th, there was short interest totaling 6,297,057...

GRAIL Announces Retirement of CEO Bob Ragusa and Appointment of Josh Ofman, MD, MSHS, as Successor

GRAIL Announces Retirement of CEO Bob Ragusa and Appointment of Josh Ofman, MD, MSHS, as Successor GRAIL Announces Retirement of CEO Bob Ragusa and Appointment of Josh Ofman, MD, MSHS, as Successor...

GRAIL (NASDAQ:GRAL) CEO Robert Ragusa Sells 7,461 Shares

GRAIL, Inc. (NASDAQ:GRAL - Get Free Report) CEO Robert Ragusa sold 7,461 shares of the business's stock in a transaction dated Monday, March 9th. The shares were sold at an average price of $47.89...

GRAIL (NASDAQ:GRAL) CEO Sells $51,949.80 in Stock

GRAIL, Inc. (NASDAQ:GRAL - Get Free Report) CEO Robert Ragusa sold 980 shares of GRAIL stock in a transaction on Thursday, March 5th. The stock was sold at an average price of $53.01, for a total...

Insider Selling: GRAIL (NASDAQ:GRAL) CEO Sells 7,461 Shares of Stock

GRAIL, Inc. (NASDAQ:GRAL - Get Free Report) CEO Robert Ragusa sold 7,461 shares of the stock in a transaction that occurred on Monday, March 9th. The shares were sold at an average price of $47.89...

GRAIL, Inc. operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T. Huber, William H. Rastetter, Mostafa Ronaghi, and Richard D. Klausner on September 11, 2015 and is headquartered in Menlo Park, CA.

GRAL
GRAIL Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest GRAL News

GRALGRAIL Inc.